Get the Stockscreener App
0.6993
2.84%
0.0193
After Hours:
.68
-0.0193
-2.76%
Unity Biotechnology Inc Stock (UBX) Forecast
The Unity Biotechnology Inc (UBX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $12.25, representing a +1,652% increase from the current price of $0.6993. The highest analyst price target is $24.14, and the lowest is $0.3616.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month UBX Price Target
Average 39.40
(+5,535% Upside)
Is Unity Biotechnology Inc (UBX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 33.17 | Neutral |
| STOCH(9,6) | 18.16 | Buy |
| STOCHRSI(14) | 55.15 | Neutral |
| MACD(12,26) | -0.0929 | Sell |
| ADX(14) | 21.31 | Neutral |
| William %R | -86.45 | Buy |
| CCI(14) | -48.19 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7488
Sell
|
0.7457
Sell
|
| MA20 |
0.8266
Sell
|
0.8123
Sell
|
| MA50 |
0.9752
Sell
|
1.0076
Sell
|
| MA100 |
1.4404
Sell
|
1.1977
Sell
|
| MA200 |
1.3833
Sell
|
1.3408
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, UBX could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on UBX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 33.17 indicates that UBX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 18.16 indicates that UBX is oversold. This indicates that UBX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 55.15 indicates that UBX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.31 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -48.19 indicates that UBX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term UBX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Unity Biotechnology Inc financial reports and earnings history, Unity Biotechnology Inc (UBX) stock could reach $113.79 by 2030, $68.61 by 2040 and $218.75 by 2050. See the projected annual prices until 2050 of the Unity Biotechnology Inc stock below:
- Unity Biotechnology Inc (UBX) is expected to reach an average price of $19.82 in 2035, with a high prediction of $22.63 and a low estimate of $19.98. This indicates an $2,734% rise from the last recorded price of $0.6993.
- Unity Biotechnology Inc (UBX) stock is projected to chart a bullish course in 2040, with an average price target of $65.10, representing an $9,210% surge from its current level. The forecast ranges from a conservative $65.23 to a sky-high $68.61.
- Our analysts predict Unity Biotechnology Inc (UBX) to jump 18,523% by 2045, soaring from $130.41 to an average price of $130.23, potentially reaching $132.85. While $130.41 is the low estimate, the potential upside is significant.
- Unity Biotechnology Inc (UBX) stock is expected to climb by 2050, reaching an average of $211.70, a $30,173% jump from its current level. However, a wide range of estimates exists, with high and low targets of $218.75 and $215.54, respectively, highlighting the market's uncertainty.
Unity Biotechnology Inc Stock (UBX) Year by Year Forecast
Unity Biotechnology Inc Stock (UBX) Price Forecast for 2025
Unity Biotechnology Inc Stock (UBX) is expected to reach an average price of $39.40 in 2025, with a high prediction of $78.44 and a low estimate of $0.3616. This indicates an +5,535% rise from the last recorded price of $0.6993.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $17.71 | $0.3616 | $24.14 | +2,433% |
| August, 2025 | $1.6412 | $2.1412 | $18.35 | +134.69% |
| September, 2025 | $28.01 | $4.8034 | $35.81 | +3,905% |
| October, 2025 | $44.31 | $30.04 | $78.44 | +6,236% |
| November, 2025 | $38.66 | $39.76 | $42.07 | +5,429% |
| December, 2025 | $32.88 | $33.58 | $37.43 | +4,602% |
Unity Biotechnology Inc Stock (UBX) Price Forecast for 2026
The predicted value for Unity Biotechnology Inc (UBX) in 2026 is set at an average of $16.25. Estimates vary from a peak of $31.61 to a trough of $0.892, indicating an +2,224% surge from the present price of $0.6993.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $6.6327 | $20.53 | $27.04 | +848.48% |
| February, 2026 | $15.09 | $10.12 | $5.0592 | +2,057% |
| March, 2026 | $1.6613 | $8.7387 | $9.649 | +137.56% |
| April, 2026 | $11.45 | $2.952 | $31.61 | +1,537% |
| May, 2026 | $5.792 | $0.892 | $15.38 | +728.26% |
| June, 2026 | $4.861 | $3.3977 | $7.1288 | +595.12% |
| July, 2026 | $19.48 | $10.52 | $14.88 | +2,685% |
| August, 2026 | $12.93 | $15.03 | $15.34 | +1,749% |
| September, 2026 | $13.55 | $14.97 | $14.86 | +1,837% |
| October, 2026 | $20.10 | $20.51 | $19.00 | +2,774% |
| November, 2026 | $23.75 | $22.26 | $23.35 | +3,297% |
| December, 2026 | $24.07 | $23.48 | $23.72 | +3,342% |
Unity Biotechnology Inc Stock (UBX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Unity Biotechnology Inc (UBX) is $30.76, with a high forecast of $36.39 and a low forecast of $25.13. This indicates an +4,299% increase from the last price of $0.6993.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $30.32 | $25.13 | $28.72 | +4,236% |
| February, 2027 | $25.37 | $26.37 | $28.29 | +3,529% |
| March, 2027 | $33.69 | $29.04 | $32.01 | +4,718% |
| April, 2027 | $33.54 | $33.68 | $33.35 | +4,697% |
| May, 2027 | $36.80 | $36.11 | $35.37 | +5,162% |
| June, 2027 | $37.82 | $36.88 | $36.39 | +5,308% |
| July, 2027 | $32.77 | $32.80 | $35.46 | +4,586% |
| August, 2027 | $33.12 | $31.93 | $31.92 | +4,636% |
| September, 2027 | $32.66 | $33.28 | $33.11 | +4,571% |
| October, 2027 | $33.69 | $32.70 | $32.80 | +4,717% |
| November, 2027 | $32.24 | $32.44 | $32.95 | +4,511% |
| December, 2027 | $23.46 | $28.21 | $30.20 | +3,254% |
Unity Biotechnology Inc Stock (UBX) Price Forecast for 2028
In 2028, Unity Biotechnology Inc (UBX) is projected to reach an average price of $23.33, with a high projection of $30.43 and a low estimate of $16.23. This indicates an +3,237% rise from the last price of $0.6993.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $30.71 | $30.42 | $30.43 | +4,292% |
| February, 2028 | $29.91 | $29.93 | $29.62 | +4,178% |
| March, 2028 | $29.32 | $29.65 | $29.42 | +4,093% |
| April, 2028 | $28.24 | $28.60 | $28.96 | +3,939% |
| May, 2028 | $26.33 | $26.55 | $27.71 | +3,665% |
| June, 2028 | $23.49 | $23.95 | $26.00 | +3,259% |
| July, 2028 | $22.07 | $22.25 | $22.79 | +3,055% |
| August, 2028 | $20.98 | $20.90 | $21.50 | +2,900% |
| September, 2028 | $21.92 | $20.77 | $21.76 | +3,035% |
| October, 2028 | $19.74 | $19.99 | $21.02 | +2,723% |
| November, 2028 | $17.20 | $17.44 | $18.75 | +2,360% |
| December, 2028 | $16.50 | $16.23 | $16.24 | +2,259% |
Unity Biotechnology Inc Stock (UBX) Price Forecast for 2029
The 2029 price forecast for Unity Biotechnology Inc Stock (UBX) is $49.52 on average, with a high prediction of $98.68 and a low estimate of $0.3529. This represents an +6,981% increase from the previous price of $0.6993.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $14.59 | $14.60 | $15.58 | +1,987% |
| February, 2029 | $13.56 | $13.78 | $14.04 | +1,839% |
| March, 2029 | $12.12 | $12.24 | $13.02 | +1,633% |
| April, 2029 | $11.57 | $11.65 | $11.73 | +1,555% |
| May, 2029 | $9.8386 | $9.8386 | $10.77 | +1,307% |
| June, 2029 | $8.3716 | $8.4316 | $9.1418 | +1,097% |
| July, 2029 | $7.0146 | $7.3846 | $7.9649 | +903.09% |
| August, 2029 | $5.5309 | $5.5909 | $6.6025 | +690.92% |
| September, 2029 | $4.1139 | $4.2139 | $5.1441 | +488.29% |
| October, 2029 | $2.6601 | $2.7301 | $3.6571 | +280.40% |
| November, 2029 | $1.3832 | $1.3832 | $2.2334 | +97.79% |
| December, 2029 | $98.98 | $0.3529 | $98.68 | +14,054% |
Unity Biotechnology Inc Stock (UBX) Price Forecast for 2030
Unity Biotechnology Inc Stock (UBX) is expected to reach an average price of $116.74 in 2030, with a high forecast of $128.33 and a low forecast of $105.14. This signifies an +16,593% surge from the last price of $0.6993.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $110.41 | $112.41 | $113.79 | +15,689% |
| February, 2030 | $109.32 | $114.19 | $106.55 | +15,533% |
| March, 2030 | $124.32 | $120.25 | $118.63 | +17,678% |
| April, 2030 | $128.63 | $126.15 | $128.33 | +18,294% |
| May, 2030 | $125.26 | $119.11 | $122.06 | +17,813% |
| June, 2030 | $114.77 | $119.47 | $115.59 | +16,312% |
| July, 2030 | $111.70 | $113.67 | $112.72 | +15,873% |
| August, 2030 | $104.81 | $105.91 | $99.85 | +14,888% |
| September, 2030 | $102.71 | $105.16 | $102.69 | +14,588% |
| October, 2030 | $110.85 | $105.14 | $104.35 | +15,751% |
| November, 2030 | $113.75 | $109.97 | $111.35 | +16,167% |
| December, 2030 | $110.96 | $110.83 | $111.58 | +15,767% |
1.89%
3.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):